BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24666374)

  • 1. MUC 4-negative FUS-CREB3L2 rearranged low-grade fibromyxoid sarcoma.
    Linos K; Bridge JA; Edgar MA
    Histopathology; 2014 Nov; 65(5):722-4. PubMed ID: 24666374
    [No Abstract]   [Full Text] [Related]  

  • 2. Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.
    Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F
    Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
    Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
    Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetically confirmed low-grade fibromyxoid sarcoma arising from the tibia.
    Mazari PM; Weber KL; Kim S; Zhang PJ
    Hum Pathol; 2016 Feb; 48():56-9. PubMed ID: 26772399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade fibromyxoid sarcoma: an unusual cardiac location.
    Ferlosio A; Doldo E; Polisca P; Orlandi A
    Cardiovasc Pathol; 2013; 22(3):e15-7. PubMed ID: 23290535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2021 Nov; 34(6):1919-1928. PubMed ID: 34535876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
    Matsuyama A; Hisaoka M; Shimajiri S; Hashimoto H
    Diagn Mol Pathol; 2008 Dec; 17(4):237-40. PubMed ID: 18382348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade fibromyxoid sarcoma with prominent giant rosettes and heterotopic ossification.
    Hisaoka M; Matsuyama A; Aoki T; Sakamoto A; Yokoyama K
    Pathol Res Pract; 2012 Sep; 208(9):557-60. PubMed ID: 22819758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1.
    Möller E; Hornick JL; Magnusson L; Veerla S; Domanski HA; Mertens F
    Clin Cancer Res; 2011 May; 17(9):2646-56. PubMed ID: 21536545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma.
    Rose B; Tamvakopoulos GS; Dulay K; Pollock R; Skinner J; Briggs T; Cannon S
    J Orthop Surg Res; 2011 Mar; 6():15. PubMed ID: 21406083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
    Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
    Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I
    Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deeply located low-grade fibromyxoid sarcoma with FUS-CREB3L2 gene fusion in a 5-year-old boy with review of literature.
    Kurisaki-Arakawa A; Suehara Y; Arakawa A; Takagi T; Takahashi M; Mitani K; Kaneko K; Yao T; Saito T
    Diagn Pathol; 2014 Sep; 9():163. PubMed ID: 25183312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera.
    Panagopoulos I; Möller E; Dahlén A; Isaksson M; Mandahl N; Vlamis-Gardikas A; Mertens F
    Genes Chromosomes Cancer; 2007 Feb; 46(2):181-91. PubMed ID: 17117415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
    Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H
    Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade fibromyxoid sarcoma of the extremities: a clinicopathologic study of 24 cases and review of the literature.
    Sambri A; Righi A; Tuzzato G; Donati D; Bianchi G
    Pol J Pathol; 2018; 69(3):219-225. PubMed ID: 30509048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.
    Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR
    Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
    Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
    Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary intracranial low-grade fibromyxoid sarcoma with FUS gene rearrangement.
    Chen N; Gong J; Nie L; Chen X; Xu M; Chen M; Zhou Q
    Neuropathology; 2015 Aug; 35(4):348-53. PubMed ID: 25828939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.